Overall N = 2382 (100%) | Survivors reporting chest wall abnormalities N = 48 (2.0, 95%CI 1.5–2.7) | ||||
---|---|---|---|---|---|
n | %a | n | %b | (95%CI) | |
Sex | |||||
Female | 1111 | 46.6% | 16 | 1.4% | (0.8–2.3) |
Male | 1271 | 53.4% | 32 | 2.5% | (1.8–3.5) |
Age at diagnosis (years) | |||||
0–5 | 1108 | 46.5% | 20 | 1.8% | (1.2–2.8) |
6–10 | 521 | 21.9% | 7 | 1.3% | (0.6–2.8) |
11–15 | 540 | 22.7% | 12 | 2.2% | (1.3–3.9) |
16–20 | 213 | 8.9% | 9 | 4.2% | (2.2–7.9) |
Median (IQR) age at study (years) | 31.1 | (24.6–38.2) | 32.1 | (25.8–38.1) | |
Year of diagnosis | |||||
1976–1990 | 845 | 35.5% | 18 | 2.1% | (1.3–3.4) |
1991–2005 | 1537 | 64.5% | 30 | 2.0% | (1.4–2.8) |
Diagnosis | |||||
I: Leukemia | 773 | 32.5% | 5 | 0.6% | (0.2–1.5) |
II: Lymphoma | 428 | 17.9% | 16 | 3.7% | (2.3–6.0) |
III: CNS tumor | 345 | 14.5% | 13 | 3.8% | (2.2–6.4) |
IV–XII: Other tumors | 836 | 35.1% | 14 | 1.7% | (1.0–2.8) |
Thoracic radiotherapy c | |||||
No | 2075 | 87.1% | 31 | 1.5% | (1.1–2.1) |
Yes | 307 | 12.9% | 17 | 5.5% | (3.5–8.7) |
Surgery to the chest d | |||||
No | 2290 | 96.1% | 41 | 1.8% | (1.3–2.4) |
Yes | 92 | 3.9% | 7 | 7.6% | (3.7–15.2) |
Any chemotherapy | |||||
No | 414 | 17.4% | 6 | 1.4% | (0.7–3.2) |
Yes | 1968 | 82.6% | 42 | 2.1% | (1.6–2.9) |